CQ31
Selleck Chemicals
SKU:E1138-5MG
Couldn't load pickup availability
CQ31 is an activator linked to Viral Entry / Replication and related pathway-oriented research. In practice, this places the compound in experiments that measure host-pathogen interactions, entry mechanisms, and replication-associated responses in infectious disease models.
The pathway annotation connects CQ31 to Viral Entry / Replication, supporting experiments that monitor host-pathogen interactions, entry mechanisms, and replication-associated responses across biochemical, cellular, or phenotypic assay formats. This context is compatible with viral entry, replication, and host-response phenotyping, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In infectious disease models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Pathway perturbation studies connected to Viral Entry / Replication
- Gain-of-function pathway-activation studies
- Phenotypic profiling in infectious disease models
- Combination studies with orthogonal perturbagens
Overall, CQ31 is well suited to pathway-oriented studies that need a defined compound input for Viral Entry / Replication readouts in infectious disease models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Pathways:
- Viral Entry / Replication
- Research Area:
- Infectious Disease
- CAS No.:
- 441022-67-9
- Molecular Weight:
- 272.34
- Formula:
- C₁₃H₂₄N₂O₄
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.